United States · 
Who invested in Amplo Biotechnology?
Amplo Biotechnology's investors include National Institutes of Health and Casdin Capital.
United States · Funded startup
Who invested in Amplo Biotechnology
Funding summaryUpdated 26 Oct 2026
$2.9Mraised across 1 round since 2025, from 1 source
- Latest round
- Grant, $2.9MJan 2025
- Investors
- 2
The rounds
- Jan 2025
Founders and team
From Amplo Biotechnology's own website and the SEC filings it signed: 4 on the team.
- Patricio SepulvedaCEO
- Claudia CanzonettaProgram Director
- Dan BradburyExecutive Chair
- Paul HawkinsExecutive Officer, Directori
On the board, as filediDaniel BradburyJean KimMatthew PaulsTerry Vance
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Amplo Biotechnology as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Amplo Biotechnology
How much has Amplo Biotechnology raised?
Amplo Biotechnology has raised $2.9M across 1 round since 2025.
When did Amplo Biotechnology last raise?
Amplo Biotechnology's most recent round was a Grant of $2.9M in Jan 2025.
What was Amplo Biotechnology's biggest round?
Its most recent round, $2.9M in Jan 2025, is also its largest on record.
Who backed Amplo Biotechnology first?
Amplo Biotechnology's first round on record, in Jan 2025, was backed by National Institutes of Health and Casdin Capital.
What stage is Amplo Biotechnology at?
Amplo Biotechnology's latest named round is a Grant, in Jan 2025.
Where is Amplo Biotechnology based?
Amplo Biotechnology is based in the United States.
Companies like Amplo Biotechnology
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.